Slide Insurance insider sells 52,690 shares via plan
Slide Insurance Holdings, Inc. director and executive Lucas Shannon reported open-market sales of 52,690 shares of common stock associated with entities he is related to.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Slide Insurance Holdings, Inc. director and executive Lucas Shannon reported open-market sales of 52,690 shares of common stock associated with entities he is related to. On April 9, 2026, Securus Risk Management LLC sold 27,069 shares at a weighted average price of $18.11 per share, and on April 13, 2026 it sold 25,621 shares at a weighted average price of $18.05 per share, all under a pre-arranged Rule 10b5-1 trading plan.
After these sales, Securus Risk Management LLC held 1,401,448 shares of Slide Insurance common stock, while Shannon also held 208,101 shares directly. Footnotes indicate substantial additional indirect holdings through his spouse and related trusts and LLCs, and state that he disclaims beneficial ownership beyond his pecuniary interest.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 25,621 | $18.05 | $462K |
| Sale | Common Stock | 27,069 | $18.11 | $490K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (10)
- F1. Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 21, 2025.
- F2. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.22 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F3. The securities reported herein are held by Securus Risk Management LLC, which is an entity controlled by the Reporting Person. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F4. Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $18.00 to $18.15 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.
- F5. Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F6. The amount shown reflects the amount owned by the Reporting Person's spouse after the sale of 532,757 shares of common stock between April 9-13, 2026, pursuant to a 10b5-1 trading plan, at prices ranging from $18.00 to $18.22 per share.
- F7. Represent shares of common stock beneficially owned by the Reporting Person's spouse through IIM Holdings II, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F8. Represent shares held through the Emma Cloonen Irrevocable Trust, of which the Reporting Person's spouse is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F9. Represent shares held through the Ava Cloonen Irrevocable Trust, of which the Reporting Person's spouse is the trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F10. Represent shares of common stock held by the Reporting Person's spouse through Bruce Lucas Irrevocable Grantor Retained Annuity Trust of 2014. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Key Figures
Key Terms
Rule 10b5-1 trading plan regulatory
weighted average price financial
beneficial ownership regulatory
pecuniary interest financial
Grantor Retained Annuity Trust financial
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Slide Insurance (SLDE) report for Lucas Shannon?
Did the Slide Insurance (SLDE) insider trades occur under a Rule 10b5-1 plan?
What Slide Insurance (SLDE) holdings does Lucas Shannon report after these transactions?
AI-generated analysis. How Rhea-AI works. Not financial advice.